13F HOLDINGS REPORT
Novo Holdings A/S
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001388325-26-000007
Total Value
$1.29B
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BROOKFIELD CORP | 11271J107 | 3,496,245 | $160.4M | 12.46% |
| 2 | EDGEWISE THERAPEUTICS INC | EWTX | 5,350,000 | $132.8M | 10.31% |
| 3 | ASML HOLDING N V | ASMLF | 113,946 | $121.9M | 9.47% |
| 4 | MIRUM PHARMACEUTICALS INC | MIRM | 1,264,028 | $99.8M | 7.75% |
| 5 | SALESFORCE INC | CRM | 330,187 | $87.5M | 6.79% |
| 6 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,625,000 | $75.6M | 5.87% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,380,000 | $74.1M | 5.75% |
| 8 | MAPLIGHT THERAPEUTICS INC | MPLT | 3,686,622 | $64.8M | 5.03% |
| 9 | ZENAS BIOPHARMA INC | ZBIO | 1,450,000 | $52.6M | 4.09% |
| 10 | PHARVARIS N V | PHVS | 1,750,000 | $48.6M | 3.77% |
| 11 | APOGEE THERAPEUTICS INC | APGE | 570,000 | $43.0M | 3.34% |
| 12 | VAXCYTE INC | PCVX | 916,160 | $42.3M | 3.28% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 660,000 | $39.2M | 3.05% |
| 14 | ARRIVENT BIOPHARMA INC | AVBP | 1,942,142 | $39.1M | 3.03% |
| 15 | ALIBABA GROUP HLDG LTD | BBAAY | 257,327 | $37.7M | 2.93% |
| 16 | INSMED INC | INSM | 200,000 | $34.8M | 2.70% |
| 17 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,200,000 | $32.6M | 2.53% |
| 18 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 3,650,737 | $27.4M | 2.13% |
| 19 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 1,961,317 | $24.6M | 1.91% |
| 20 | ENLIVEN THERAPEUTICS INC | ELVN | 1,480,000 | $22.8M | 1.77% |
| 21 | VALNEVA SE | VALN | 2,305,000 | $20.3M | 1.58% |
| 22 | LANZATECH GLOBAL INC | LNZAW | 158,148 | $2.2M | 0.17% |
| 23 | MARQETA INC | MQ | 441,558 | $2.1M | 0.16% |
| 24 | IO BIOTECH INC | IOBT | 2,512,453 | $1.5M | 0.12% |